Cytosorbents Corporation CTSO
4.38
0.08
1.86%
as of 25 Sep
- Market cap
- $13.6M
- P/E
- 0.0×
Follow CTSO
Growth Flags
show if company had growth for consecutive years,
Insider Buys
alert about insiders buying in the last 12 month
| Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
P/S ratio |
0.75 | 0.60 | 0.55 | 0.25 | 0.38 | 0.21 | 0.11 | 0.08 | 0.07 | 0.05 |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
P/Operating CF |
(6.66) | (22.08) | (4.58) | (1.51) | (14.62) | (1.65) | (0.74) | (0.37) | (1.06) | (0.41) |
P/B ratio |
5.37 | 0.88 | 0.73 | 1.82 | 0.20 | 0.15 | 0.11 | 0.10 | 0.22 | 0.34 |
Price to Tangible BV |
5.37 | 0.88 | 0.73 | 109.51 | 0.21 | 0.16 | 0.13 | 0.13 | 0.34 | 0.74 |
EV/Sales |
0.72 | 0.11 | 0.00 | 0.36 | (1.34) | (0.68) | (0.38) | (0.22) | 0.30 | 0.40 |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | 5.85 | 1.35 | 0.43 | 0.22 | 0.00 | 0.00 |
EV/Operating CF |
(1.02) | (0.27) | 0.00 | (0.54) | 9.78 | 2.09 | 0.46 | 0.31 | (0.74) | (1.20) |
EV/FCF |
(0.94) | (0.21) | 0.00 | (0.49) | 7.53 | 1.60 | 0.38 | 0.30 | (0.71) | (1.17) |
Quick Ratio |
1.56 | 2.49 | 3.80 | 1.68 | 7.54 | 4.14 | 2.86 | 1.44 | 1.59 | 1.42 |
Current Ratio |
1.83 | 2.64 | 4.09 | 2.10 | 8.12 | 4.70 | 3.48 | 1.81 | 2.20 | 2.13 |
Net Debt/EBITDA |
0.03 | 0.77 | 0.82 | (0.15) | 7.50 | 1.77 | 0.56 | 0.30 | (0.40) | (0.85) |
Debt/Assets |
50.67% | 41.46% | 29.07% | 54.97% | 1.14% | 15.44% | 8.08% | 9.52% | 29.54% | 37.72% |
Debt/Equity |
3.67 | 0.97 | 0.59 | 4.40 | 0.01 | 0.22 | 0.14 | 0.21 | 1.26 | 2.82 |
Asset Turnover |
0.91 | 0.90 | 0.77 | 0.81 | 0.70 | 0.48 | 0.45 | 0.54 | 0.71 | 0.81 |
Operating CF/Net income |
0.57 | 0.73 | 0.63 | 0.87 | 0.72 | 0.57 | 0.86 | 0.74 | 0.70 | 1.51 |
Capex/Depreciation |
(3.10) | (5.59) | (3.12) | (2.18) | (1.70) | (3.79) | (5.70) | (0.46) | (0.31) | (0.17) |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| (246.41%) | (151.66%) | (126.57%) | (189.32%) | (18.97%) | (34.64%) | (67.00%) | (99.38%) | (119.80%) | (96.39%) | |
| (112.31%) | (52.05%) | (59.04%) | (62.57%) | (13.36%) | (27.37%) | (42.96%) | (50.34%) | (41.30%) | (17.91%) | |
ROIC |
(715.47%) | (209.74%) | (216.12%) | (190.11%) | (73.46%) | (58.59%) | (107.43%) | (138.73%) | (61.12%) | (56.48%) |
Return on Tangible Assets |
(285.54%) | (61.54%) | (74.58%) | (149.46%) | (10.53%) | (44.04%) | (94.32%) | (136.54%) | (99.70%) | (43.73%) |
Average Days of Receivables |
54.92 | 53.14 | 63.95 | 65.35 | 45.93 | 38.25 | 59.61 | 71.12 | 75.06 | 74.35 |
Research and Development Expense of Revenue |
42.75% | 21.26% | 34.32% | 48.47% | 21.49% | 37.95% | 43.58% | 50.17% | 21.37% | 13.72% |
Selling, General and Administrative Expense of Revenue |
123.94% | 98.44% | 92.76% | 88.20% | 69.42% | 82.82% | 98.84% | 123.23% | 94.77% | 96.17% |
Intangible Assets out of Total Assets |
0.12 | 0.08 | 0.08 | 0.12 | 0.05 | 0.05 | 0.07 | 0.00 | 0.08 | 0.07 |
Share Based Compensation of Revenue |
33.46% | 26.43% | 23.93% | 11.38% | 11.48% | 14.37% | 10.95% | 13.37% | 10.56% | 7.46% |
Graham Net Nets |
(0.07) | 0.76 | 0.89 | (0.49) | 4.64 | 4.11 | 1.49 | (1.71) | (5.92) | (8.86) |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Earnings Yield |
(157.87%) | (92.23%) | (138.61%) | (311.69%) | (50.19%) | (272.08%) | (832.23%) | (1,196.26%) | (835.16%) | (406.25%) |
Free Cash Flow Yield |
(101.97%) | (90.00%) | (99.59%) | (294.38%) | (47.12%) | (201.31%) | (874.85%) | (945.60%) | (609.55%) | (642.35%) |
Revenue per Share |
7.49 | 10.97 | 14.65 | 15.47 | 21.13 | 19.91 | 15.92 | 13.92 | 13.08 | 11.91 |
Operating CF per Share |
(5.29) | (4.68) | (7.06) | (10.39) | (2.89) | (6.46) | (12.96) | (9.70) | (5.30) | (3.98) |
Capex per Share |
(0.47) | (1.22) | (0.99) | (0.94) | (0.86) | (1.97) | (2.96) | (0.42) | (0.25) | (0.13) |
Free Cash Flow per Share |
(5.76) | (5.89) | (8.05) | (11.33) | (3.76) | (8.43) | (15.92) | (10.12) | (5.55) | (4.11) |
Cash per Share |
4.12 | 12.55 | 14.56 | 7.58 | 36.80 | 24.05 | 10.16 | 6.33 | 3.04 | 2.01 |
Shareholders Equity per Share |
1.05 | 7.43 | 11.03 | 2.12 | 40.81 | 28.86 | 16.24 | 10.52 | 4.08 | 1.90 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
1.05 | 7.43 | 11.03 | 2.12 | 40.81 | 28.86 | 16.24 | 10.52 | 4.08 | 1.90 |
Free Cash Flow |
(7.33) | (8.14) | (12.36) | (18.28) | (7.29) | (18.29) | (34.69) | (22.59) | (15.10) | (12.79) |
Working Capital |
3.55 | 12.89 | 21.35 | 10.97 | 72.30 | 50.61 | 24.05 | 11.36 | 11.78 | 10.93 |
Capital Expenditures |
(0.60) | (1.68) | (1.52) | (1.52) | (1.68) | (4.28) | (6.46) | (0.94) | (0.67) | (0.41) |
Net Current Asset Value |
(0.53) | 6.90 | 11.00 | (3.06) | 71.72 | 37.36 | 5.90 | (4.08) | (14.66) | (17.64) |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | 5.30 | 1.29 | 0.41 | 0.21 | 0.00 | 0.00 |
Capex to Sales |
0.06 | 0.11 | 0.07 | 0.06 | 0.04 | 0.10 | 0.19 | 0.03 | 0.02 | 0.01 |
Net Profit Margin |
(123.47%) | (58.06%) | (76.48%) | (77.22%) | (19.11%) | (56.89%) | (94.59%) | (94.09%) | (58.21%) | (22.12%) |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.34 | 0.21 | 0.28 | 0.36 | 0.46 | 0.22 | 0.11 | 0.20 | 0.24 | 0.31 |
Cash ROIC |
(63.51%) | (20.93%) | (25.52%) | (60.86%) | (5.10%) | (14.90%) | (62.24%) | (74.34%) | (70.19%) | (70.09%) |
Accounts Receivable Turnover |
9.15 | 8.33 | 7.32 | 5.93 | 8.52 | 8.92 | 6.81 | 5.30 | 5.32 | 4.98 |
Accounts Payable Turnover |
3.92 | 4.29 | 5.49 | 4.18 | 5.71 | 4.76 | 6.26 | 3.35 | 3.00 | 3.41 |
Inventory Turnover |
3.91 | 6.77 | 9.20 | 5.00 | 4.62 | 2.97 | 3.39 | 2.67 | 3.51 | 2.64 |
Average Days of Payables |
122.79 | 82.31 | 72.41 | 101.08 | 60.60 | 92.68 | 43.29 | 151.98 | 113.85 | 99.05 |
Days of Inventory on Hand |
76.99 | 52.63 | 40.60 | 104.78 | 88.30 | 157.47 | 90.53 | 134.93 | 93.16 | 182.33 |
Average Receivables |
1.04 | 1.82 | 3.07 | 4.21 | 4.81 | 4.84 | 5.09 | 5.86 | 6.69 | 7.44 |
Average Payables |
1.01 | 1.29 | 1.37 | 1.76 | 1.94 | 2.32 | 2.23 | 2.73 | 3.57 | 3.10 |
Average Inventory |
1.01 | 0.81 | 0.81 | 1.47 | 2.39 | 3.72 | 4.11 | 3.42 | 3.05 | 4.01 |
Average Assets |
10.47 | 16.90 | 29.15 | 30.79 | 58.67 | 89.73 | 76.38 | 58.09 | 50.16 | 45.78 |
Average Common Equity |
4.77 | 5.80 | 13.60 | 10.18 | 41.32 | 70.90 | 48.98 | 29.43 | 17.29 | 8.51 |
Columns are period end dates